Orthopedic Devices - Israel

  • Israel
  • The Orthopedic Devices market market in Israel is anticipated to achieve a revenue of US$260.60m by the year 2024.
  • It is projected to experience a steady annual growth rate (CAGR 2024-2029) of 4.91%, leading to a market volume of US$331.20m by 2029.
  • When compared globally, the United States is expected to generate the highest revenue, amounting to US$16,020.00m in 2024.
  • Israel is at the forefront of technological advancements in orthopedic devices, with a strong focus on innovative solutions for personalized patient care.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in Israel is experiencing steady growth due to increasing customer preferences for technologically advanced and innovative products.

Customer preferences:
Customers in the Orthopedic Devices market in Israel are increasingly seeking products that offer advanced features and improved functionality. They are willing to invest in high-quality orthopedic devices that can provide better outcomes and enhance their quality of life. Additionally, there is a growing demand for minimally invasive procedures and devices that can reduce recovery time and improve patient comfort.

Trends in the market:
One of the key trends in the Orthopedic Devices market in Israel is the adoption of robotic-assisted surgeries. Robotic systems enable surgeons to perform complex procedures with greater precision and accuracy. This technology has gained popularity among both patients and healthcare providers, as it offers improved surgical outcomes and reduces the risk of complications. Another trend in the market is the development of 3D printing technology for orthopedic devices. This technology allows for the customization of implants and prosthetics, resulting in better fit and functionality for patients.

Local special circumstances:
Israel has a strong healthcare system and is known for its technological advancements in the medical field. The country has a high concentration of medical device companies, including those specializing in orthopedic devices. The presence of these companies fosters innovation and drives the development of new and advanced orthopedic devices in the market. Additionally, Israel has a growing elderly population, which is driving the demand for orthopedic devices such as joint replacements and mobility aids.

Underlying macroeconomic factors:
Israel has a stable economy with a strong focus on research and development. The government provides support and incentives for companies in the healthcare sector, which encourages innovation and investment in the Orthopedic Devices market. Additionally, the country has a well-developed healthcare infrastructure and a high level of healthcare expenditure, which supports the demand for orthopedic devices. The increasing prevalence of chronic diseases, such as osteoarthritis and osteoporosis, also contributes to the growth of the market as these conditions often require orthopedic interventions. In conclusion, the Orthopedic Devices market in Israel is driven by customer preferences for technologically advanced products, including robotic-assisted surgeries and 3D printed devices. The local special circumstances, such as the presence of medical device companies and the growing elderly population, further contribute to the market growth. The underlying macroeconomic factors, including a stable economy and government support, also play a significant role in the development of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)